Rankings
▼
Calendar
VCEL Q3 2016 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena
VCEL
Vericel Corporation
$2B
Q3 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$11M
Gross Profit
$4M
37.3% margin
Operating Income
-$6M
-58.4% margin
Net Income
-$7M
-61.1% margin
EPS (Diluted)
$-0.29
QoQ Revenue Growth
-14.8%
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$4M
Stock-Based Comp.
$654,000
Balance Sheet
Total Assets
$28M
Total Liabilities
$17M
Stockholders' Equity
$11M
Cash & Equivalents
$9M
← FY 2016
All Quarters
Q4 2016 →